| Q24289227 | A Bayesian measure of the probability of false discovery in genetic epidemiology studies |
| Q24609382 | A CLEC16A variant confers risk for juvenile idiopathic arthritis and anti-cyclic citrullinated peptide antibody negative rheumatoid arthritis |
| Q35993541 | A Combination of CD28 (rs1980422) and IRF5 (rs10488631) Polymorphisms Is Associated with Seropositivity in Rheumatoid Arthritis: A Case Control Study |
| Q83072348 | A PTPN22 promoter polymorphism -1123G>C is associated with RA pathogenesis in Chinese |
| Q34788695 | A broad analysis of IL1 polymorphism and rheumatoid arthritis. |
| Q33519370 | A comparison of case-only designs for detecting gene x gene interaction in rheumatoid arthritis using genome-wide case-control data in Genetic Analysis Workshop 16 |
| Q36836577 | A comprehensive review of the genetics of juvenile idiopathic arthritis |
| Q21145042 | A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci |
| Q29417158 | A genome-wide association study suggests contrasting associations in ACPA-positive versus ACPA-negative rheumatoid arthritis |
| Q34247086 | A genome-wide homozygosity association study identifies runs of homozygosity associated with rheumatoid arthritis in the human major histocompatibility complex |
| Q42685398 | A genome-wide screen of gene-gene interactions for rheumatoid arthritis susceptibility |
| Q33354118 | A large-scale rheumatoid arthritis genetic study identifies association at chromosome 9q33.2. |
| Q34346378 | A phase 2 randomized, double-blind study of AMG 108, a fully human monoclonal antibody to IL-1R, in patients with rheumatoid arthritis |
| Q46452573 | A single-nucleotide polymorphism rs4639966 in 11q23.3 is associated with clinical features of systemic lupus erythematosus in the Chinese population |
| Q34043155 | A systems genetics approach provides a bridge from discovered genetic variants to biological pathways in rheumatoid arthritis |
| Q34231112 | Accounting for linkage disequilibrium in genome-wide association studies: A penalized regression method |
| Q37131055 | Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsets |
| Q33419824 | An African ancestry-specific allele of CTLA4 confers protection against rheumatoid arthritis in African Americans |
| Q41115428 | An improved synthesis of haloaceteamidine-based inactivators of protein arginine deiminase 4 (PAD4). |
| Q42659601 | Anti-CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors, cigarette smoking and other autoantibodies. |
| Q41908716 | Anti-PAD4 autoantibodies in rheumatoid arthritis: levels in serum over time and impact on PAD4 activity as measured with a small synthetic substrate |
| Q38857820 | Anti-citrullinated peptide antibodies and their value for predicting responses to biologic agents: a review |
| Q34310761 | Anti-citrullinated peptide antibody-negative RA is a genetically distinct subset: a definitive study using only bone-erosive ACPA-negative rheumatoid arthritis |
| Q38078245 | Anti-citrullinated protein antibodies: role in pathogenesis of RA and potential as a diagnostic tool |
| Q36020173 | Antibodies against cyclic citrullinated peptides of IgG, IgA and IgM isotype and rheumatoid factor of IgM and IgA isotype are increased in unaffected members of multicase rheumatoid arthritis families from northern Sweden |
| Q35605542 | Aspects of early arthritis. What determines the evolution of early undifferentiated arthritis and rheumatoid arthritis? An update from the Norfolk Arthritis Register |
| Q33519327 | Assessment of genotype imputation methods |
| Q36383132 | Association between PADI4 and rheumatoid arthritis: a meta-analysis |
| Q38609269 | Association between susceptibility to rheumatoid arthritis and PADI4 polymorphisms: a meta-analysis |
| Q45048663 | Association between transforming growth factor-beta1 T869C polymorphism and rheumatoid arthritis: a meta-analysis |
| Q39198541 | Association of IRF5 gene polymorphisms with rheumatoid arthritis in a Tunisian population. |
| Q42971880 | Association of ITGAV supports a role of angiogenesis in rheumatoid arthritis |
| Q34897145 | Association of PTPN22 1858 single-nucleotide polymorphism with rheumatoid arthritis in a German cohort: higher frequency of the risk allele in male compared to female patients |
| Q59697424 | Association of PTPN22 single nucleotide polymorphism with rheumatoid arthritis but not with allergic asthma |
| Q36054562 | Association of STAT4 with rheumatoid arthritis in the Korean population |
| Q37461361 | Association of TGFBR2 polymorphism with risk of sudden cardiac arrest in patients with coronary artery disease |
| Q34081935 | Association of TNFSF4 (OX40L) polymorphisms with susceptibility to systemic sclerosis |
| Q56968478 | Association of Variants inIL2RAWith Progression of Joint Destruction in Rheumatoid Arthritis |
| Q42139219 | Association of a Toll-like receptor 1 polymorphism with heightened Th1 inflammatory responses and antibiotic-refractory Lyme arthritis |
| Q37217463 | Association of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritis. |
| Q36732088 | Association of interleukin-6 and interleukin-10 genotypes with radiographic damage in rheumatoid arthritis is dependent on autoantibody status. |
| Q53606931 | Association of joint erosion with SLC22A4 gene polymorphisms inconsistently associated with rheumatoid arthritis susceptibility. |
| Q38246108 | Association of susceptible genetic markers and autoantibodies in rheumatoid arthritis |
| Q21195657 | Association of the FCRL3 gene with rheumatoid arthritis: a further example of population specificity? |
| Q54719990 | Associations between TRAF1-C5 gene polymorphisms and rheumatoid arthritis: a meta-analysis. |
| Q34156559 | Associations between human leukocyte antigen, PTPN22, CTLA4 genotypes and rheumatoid arthritis phenotypes of autoantibody status, age at diagnosis and erosions in a large cohort study |
| Q36171863 | Associations between the PTPN22 1858C->T polymorphism and radiographic joint destruction in patients with rheumatoid arthritis: results from a 10-year longitudinal study |
| Q34182097 | Autocitrullination of human peptidyl arginine deiminase type 4 regulates protein citrullination during cell activation |
| Q26767040 | Autoimmune diseases - connecting risk alleles with molecular traits of the immune system |
| Q38271810 | Autoimmune thyroid disease and rheumatoid arthritis: relationship and the role of genetics |
| Q34159040 | Autoimmunity to peptidyl arginine deiminase type 4 precedes clinical onset of rheumatoid arthritis. |
| Q37295607 | Bagging optimal ROC curve method for predictive genetic tests, with an application for rheumatoid arthritis |
| Q36639915 | Brief report: increased expression of a short splice variant of CTLA-4 exacerbates lupus in MRL/lpr mice |
| Q36061964 | CPAG: software for leveraging pleiotropy in GWAS to reveal similarity between human traits links plasma fatty acids and intestinal inflammation. |
| Q33332933 | Case-control association analysis of rheumatoid arthritis with candidate genes using related cases |
| Q33332926 | Case-control studies with affected sibships. |
| Q35954483 | Cia25 on rat chromosome 12 regulates severity of autoimmune arthritis induced with pristane and with collagen |
| Q38636880 | Citrullination of NF-κB p65 promotes its nuclear localization and TLR-induced expression of IL-1β and TNFα. |
| Q37894283 | Citrullination of autoantigens: upstream of TNFα in the pathogenesis of rheumatoid arthritis. |
| Q33333034 | Classification of rheumatoid arthritis status with candidate gene and genome-wide single-nucleotide polymorphisms using random forests |
| Q45983167 | Clustering of autoimmune diseases in families with a high-risk for multiple sclerosis: a descriptive study. |
| Q38489669 | Coeliac disease and rheumatoid arthritis: similar mechanisms, different antigens |
| Q31154820 | Combining linkage data sets for meta-analysis and mega-analysis: the GAW15 rheumatoid arthritis data set. |
| Q37376871 | Common variants at CD40 and other loci confer risk of rheumatoid arthritis |
| Q33333059 | Comparison of the power of haplotype-based versus single- and multilocus association methods for gene x environment (gene x sex) interactions and application to gene x smoking and gene x sex interactions in rheumatoid arthritis |
| Q55050150 | Complement in the Initiation and Evolution of Rheumatoid Arthritis. |
| Q57537211 | Complexity of a complex disease; understanding genes, environment and immunity in rheumatoid arthritis development |
| Q33332815 | Constructing gene association networks for rheumatoid arthritis using the backward genotype-trait association (BGTA) algorithm |
| Q36912113 | Contribution of genetic studies in rodent models of autoimmune arthritis to understanding and treatment of rheumatoid arthritis |
| Q34103237 | Cumulative association of 22 genetic variants with seropositive rheumatoid arthritis risk |
| Q37398076 | Current concepts in the pathogenesis of early rheumatoid arthritis |
| Q34340265 | Cytotoxic T lymphocyte-Associated Antigen +49G Variant Confers Risk for Anti-CCP- and Rheumatoid Factor-Positive Type of Rheumatoid Arthritis Only in Combination with CT60G Allele. |
| Q31154891 | Data for Genetic Analysis Workshop (GAW) 15 Problem 2, genetic causes of rheumatoid arthritis and associated traits |
| Q33519271 | Data for Genetic Analysis Workshop 16 Problem 1, association analysis of rheumatoid arthritis data |
| Q36010142 | Decreased severity of experimental autoimmune arthritis in peptidylarginine deiminase type 4 knockout mice |
| Q36633164 | Dendritic cells provide a potential link between smoking and inflammation in rheumatoid arthritis |
| Q51913204 | Detecting haplotype effects in genomewide association studies. |
| Q37454068 | Developments in the scientific understanding of rheumatoid arthritis |
| Q91742551 | Discovery of Novel Potential Reversible Peptidyl Arginine Deiminase Inhibitor |
| Q49504136 | EOMES-positive CD4+ T cells are increased in PTPN22 (1858T) risk allele carriers |
| Q35163074 | Effect of MPG gene rs2858056 polymorphism, copy number variation, and level of serum MPG protein on the risk for rheumatoid arthritis |
| Q38110963 | Emerging therapies for rheumatoid arthritis |
| Q90241455 | Epitope Specificity of Anti-Citrullinated Protein Antibodies |
| Q37710382 | Ethnogenetic heterogeneity of rheumatoid arthritis-implications for pathogenesis |
| Q33332902 | Evaluating gene x gene and gene x smoking interaction in rheumatoid arthritis using candidate genes in GAW15. |
| Q33519338 | Evaluation of an optimal receiver operating characteristic procedure |
| Q57466137 | Evidence for a direct link between PAD4-mediated citrullination and the oxidative burst in human neutrophils |
| Q34329315 | Evidence for interaction between 5-hydroxytryptamine (serotonin) receptor 2A and MHC type II molecules in the development of rheumatoid arthritis. |
| Q33333053 | Exploring epistasis in candidate genes for rheumatoid arthritis |
| Q53317555 | Functional SNPs in CD244 increase the risk of rheumatoid arthritis in a Japanese population. |
| Q38667711 | GATE: an efficient procedure in study of pleiotropic genetic associations. |
| Q33886166 | GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma |
| Q41790467 | GWASs and the age of human as the model organism for autoimmune genetic research |
| Q37161988 | Gene expression patterns in peripheral blood cells associated with radiographic severity in African Americans with early rheumatoid arthritis |
| Q36625351 | Gene network analysis of small molecules with autoimmune disease associated genes predicts a novel strategy for drug efficacy |
| Q36206856 | Gene-Based Genome-Wide Association Analysis in European and Asian Populations Identified Novel Genes for Rheumatoid Arthritis |
| Q37321287 | Gene-environment interaction between the DRB1 shared epitope and smoking in the risk of anti-citrullinated protein antibody-positive rheumatoid arthritis: all alleles are important |
| Q35752661 | Gene-gene and gene-environment interactions involving HLA-DRB1, PTPN22, and smoking in two subsets of rheumatoid arthritis |
| Q37030621 | General aspects of the genetics of SLE. |
| Q34330721 | Genetic Analysis Workshop 16: introduction to workshop summaries |
| Q38276417 | Genetic Susceptibility to ANCA-Associated Vasculitis: State of the Art. |
| Q47563245 | Genetic and environmental risk factors for rheumatoid arthritis |
| Q92981793 | Genetic architecture study of rheumatoid arthritis and juvenile idiopathic arthritis |
| Q36804396 | Genetic association meets RNA interference: large-scale genomic screens for causation and mechanism of complex diseases |
| Q46875876 | Genetic association with rheumatoid arthritis-Genetic Analysis Workshop 15: summary of contributions from Group 2. |
| Q42633268 | Genetic background of anticyclic citrullinated peptide autoantibody production in Hungarian patients with rheumatoid arthritis |
| Q34458840 | Genetic basis of autoantibody positive and negative rheumatoid arthritis risk in a multi-ethnic cohort derived from electronic health records |
| Q36790341 | Genetic polymorphisms in PTPN22, PADI-4, and CTLA-4 and risk for rheumatoid arthritis in two longitudinal cohort studies: evidence of gene-environment interactions with heavy cigarette smoking |
| Q37406567 | Genetic risk factors for rheumatoid arthritis differ in Caucasian and Korean populations |
| Q35125868 | Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk |
| Q56898912 | Genetic variants in CTLA4 are strongly associated with alopecia areata |
| Q28534348 | Genetics and epigenetics of rheumatoid arthritis |
| Q36670483 | Genetics of autoimmune diseases--disorders of immune homeostasis |
| Q37358260 | Genetics of rheumatoid arthritis: GWAS and beyond. |
| Q37873802 | Genetics of rheumatoid arthritis: what have we learned? |
| Q83151084 | Genome-wide meta-analysis for rheumatoid arthritis |
| Q54330502 | Genomic DNA pooling for whole-genome association scans in complex disease: empirical demonstration of efficacy in rheumatoid arthritis |
| Q34949404 | HLA-DRB1 shared epitope-dependent DR-DQ haplotypes are associated with both anti-CCP-positive and -negative rheumatoid arthritis in Chinese Han. |
| Q44922542 | High-density SNP analysis of 642 Caucasian families with rheumatoid arthritis identifies two new linkage regions on 11p12 and 2q33. |
| Q38101670 | How far are we from understanding the genetic basis of Hashimoto's thyroiditis? |
| Q47549698 | Human MHC-II with Shared Epitope Motifs Are Optimal Epstein-Barr Virus Glycoprotein 42 Ligands-Relation to Rheumatoid Arthritis. |
| Q37223270 | Identification of AF4/FMR2 family, member 3 (AFF3) as a novel rheumatoid arthritis susceptibility locus and confirmation of two further pan-autoimmune susceptibility genes |
| Q57307078 | Identification of HAVCR1 gene haplotypes associated with mRNA expression levels and susceptibility to autoimmune diseases |
| Q40219277 | Identification of an immunodominant peptide from citrullinated tenascin-C as a major target for autoantibodies in rheumatoid arthritis |
| Q26769061 | Identification of rheumatoid arthritis biomarkers based on single nucleotide polymorphisms and haplotype blocks: A systematic review and meta-analysis |
| Q33519380 | Identifying rheumatoid arthritis susceptibility genes using high-dimensional methods |
| Q34897654 | Immune checkpoint receptors in regulating immune reactivity in rheumatic disease |
| Q34129768 | Immunochip identifies novel, and replicates known, genetic risk loci for rheumatoid arthritis in black South Africans |
| Q54940316 | Increased levels of peptidylarginine deiminase 2 in synovial fluid from anti-CCP-positive rheumatoid arthritis patients: Association with disease activity and inflammatory markers. |
| Q34125266 | Investigation of potential non-HLA rheumatoid arthritis susceptibility loci in a European cohort increases the evidence for nine markers |
| Q31138114 | Issues in association mapping with high-density SNP data and diverse family structures |
| Q36973929 | Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. |
| Q36056599 | K-RAS GTPase- and B-RAF kinase-mediated T-cell tolerance defects in rheumatoid arthritis |
| Q33287486 | Lack of association between the chemokine receptor 5 polymorphism CCR5delta32 in rheumatoid arthritis and juvenile idiopathic arthritis |
| Q36944082 | Lack of association of functional CTLA4 polymorphisms with juvenile idiopathic arthritis |
| Q33888733 | Leveraging human genetics to develop future therapeutic strategies in rheumatoid arthritis |
| Q35616318 | Linkage proof for PTPN22, a rheumatoid arthritis susceptibility gene and a human autoimmunity gene |
| Q33895460 | Lymphoid tyrosine phosphatase and autoimmunity: human genetics rediscovers tyrosine phosphatases |
| Q34046875 | Major histocompatibility complex (MHC) class II alleles, haplotypes and epitopes which confer susceptibility or protection in systemic sclerosis: analyses in 1300 Caucasian, African-American and Hispanic cases and 1000 controls |
| Q35093031 | Mannan Binding Lectin (MBL) genotypes coding for high MBL serum levels are associated with rheumatoid factor negative rheumatoid arthritis in never smokers |
| Q36577538 | Mechanisms of disease: Genetic susceptibility and environmental triggers in the development of rheumatoid arthritis |
| Q36984881 | Mechanisms of disease: genetics of rheumatoid arthritis--ethnic differences in disease-associated genes |
| Q38223937 | Meta-analysis of SLC22A4 and RUNX1 polymorphisms : Associations with rheumatoid arthritis susceptibility. |
| Q36183352 | Meta-analysis of genetic polymorphisms in granulomatosis with polyangiitis (Wegener's) reveals shared susceptibility loci with rheumatoid arthritis |
| Q33403872 | Meta-analysis reveals an association of PTPN22 C1858T with autoimmune diseases, which depends on the localization of the affected tissue |
| Q33332783 | Meta-genetic association of rheumatoid arthritis and PTPN22 using PedGenie 2.1. |
| Q38089745 | Molecular diagnosis of celiac disease: are we there yet? |
| Q34538156 | Most common single-nucleotide polymorphisms associated with rheumatoid arthritis in persons of European ancestry confer risk of rheumatoid arthritis in African Americans |
| Q56900782 | Multiple sclerosis and the CTLA4 autoimmunity polymorphism CT60: no association in patients from Germany, Hungary and Poland |
| Q34019296 | Non-synonymous variant (Gly307Ser) in CD226 is associated with susceptibility to multiple autoimmune diseases |
| Q90617678 | Nonendocrine mechanisms of sex bias in rheumatic diseases |
| Q58544606 | Novel missense mutation in PTPN22 in a Chinese pedigree with Hashimoto's thyroiditis |
| Q44404709 | On the origins of complex immune-mediated disease: the example of rheumatoid arthritis |
| Q34027620 | Only one independent genetic association with rheumatoid arthritis within the KIAA1109-TENR-IL2-IL21 locus in Caucasian sample sets: confirmation of association of rs6822844 with rheumatoid arthritis at a genome-wide level of significance |
| Q38747640 | PAD4: pathophysiology, current therapeutics and future perspective in rheumatoid arthritis |
| Q35067455 | PADI2 is significantly associated with rheumatoid arthritis |
| Q34081898 | PADI4 genotype is not associated with rheumatoid arthritis in a large UK Caucasian population |
| Q37435917 | PADI4 haplotypes in association with RA Mexican patients, a new prospect for antigen modulation |
| Q79693938 | PADI4 polymorphisms and rheumatoid arthritis susceptibility: a meta-analysis |
| Q46677052 | PADI4 polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis |
| Q33526503 | PCA-based bootstrap confidence interval tests for gene-disease association involving multiple SNPs |
| Q57486489 | PD-L1 Regulatory B Cells Are Significantly Decreased in Rheumatoid Arthritis Patients and Increase After Successful Treatment |
| Q34031304 | PTPN22 1858C>T polymorphism distribution in Europe and association with rheumatoid arthritis: case-control study and meta-analysis |
| Q37030634 | PTPN22: its role in SLE and autoimmunity |
| Q35221741 | PTPN22: the archetypal non-HLA autoimmunity gene |
| Q40329877 | Pathogenic role of antibodies to citrullinated proteins in rheumatoid arthritis |
| Q30975961 | Pathway-based analysis of a genome-wide case-control association study of rheumatoid arthritis. |
| Q57224416 | Patients with early rheumatoid arthritis who smoke are less likely to respond to treatment with methotrexate and tumor necrosis factor inhibitors: Observations from the Epidemiological Investigation of Rheumatoid Arthritis and the Swedish Rheumatolog |
| Q47971862 | Peptidylarginine deiminase 2 is required for tumor necrosis factor alpha-induced citrullination and arthritis, but not neutrophil extracellular trap formation |
| Q36441438 | Pharmacogenetics of rheumatoid arthritis: Potential targets from susceptibility genes and present therapies |
| Q37334893 | Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases |
| Q28390545 | Pleiotropy in complex traits: challenges and strategies |
| Q36907703 | Polymorphisms in peptidylarginine deiminase associate with rheumatoid arthritis in diverse Asian populations: evidence from MyEIRA study and meta-analysis |
| Q56898076 | Polymorphisms in the CTLA-4 gene and rheumatoid arthritis susceptibility: a meta-analysis |
| Q43701467 | Polymorphisms in the interleukin 3 gene show strong association with susceptibility to Graves' disease in Chinese population. |
| Q37671218 | Prevalence of anti-peptidylarginine deiminase type 4 antibodies in rheumatoid arthritis and unaffected first-degree relatives in indigenous North American Populations. |
| Q36735401 | Primer: comparative genetics of animal models of arthritis--a tool to resolve complexity |
| Q37610857 | Promoter polymorphism (-590, T/C) of interleukin 4 (IL4) gene is associated with rheumatoid arthritis: An updated meta-analysis |
| Q42647972 | Protection against anti-citrullinated protein antibody-positive rheumatoid arthritis is predominantly associated with HLA-DRB1*1301: a meta-analysis of HLA-DRB1 associations with anti-citrullinated protein antibody-positive and anti-citrullinated pr |
| Q28242744 | Protein tyrosine phosphatase PTPN22 in human autoimmunity |
| Q45129416 | Protein tyrosine phosphatase gene C1858T allele confers risk for rheumatoid arthritis in Hungarian subjects |
| Q28238782 | Recent advances in the genetics of autoimmune disease |
| Q36958295 | Recent advances in the genetics of autoimmune diseases |
| Q36594248 | Recent advances in the genetics of rheumatoid arthritis |
| Q41968850 | Recent advances in the genetics of rheumatoid arthritis |
| Q37228388 | Recent computational approaches to understand gene regulation: mining gene regulation in silico |
| Q80219025 | Replication of reported genetic associations of PADI4, FCRL3, SLC22A4 and RUNX1 genes with rheumatoid arthritis: results of an independent Japanese population and evidence from meta-analysis of East Asian studies |
| Q27024290 | Rethinking mechanisms of autoimmune pathogenesis |
| Q57461623 | Rheumatoid Arthritis in Latin Americans Enriched for Amerindian Ancestry Is Associated With Loci in Chromosomes 1, 12, and 13, and the HLA Class II Region |
| Q57349151 | Rheumatoid arthritis |
| Q36939396 | Rheumatoid arthritis and the complement system. |
| Q37601576 | Rheumatoid arthritis genetics: 2009 update |
| Q36839197 | Rheumatoid arthritis risk allele PTPRC is also associated with response to anti-tumor necrosis factor alpha therapy |
| Q36939870 | Rheumatoid arthritis-associated RBPJ polymorphism alters memory CD4+ T cells |
| Q33519375 | Rheumatoid arthritis-associated gene-gene interaction network for rheumatoid arthritis candidate genes |
| Q37358114 | Rheumatoid arthritis: Disease or syndrome? |
| Q37315484 | Rheumatoid arthritis: a view of the current genetic landscape |
| Q38205973 | Rs7574865 polymorphism in signal transducers and activators of transcription 4 gene and rheumatoid arthritis: an updated meta-analysis of 28 case-control comparisons |
| Q37070948 | STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus |
| Q94450975 | Self-reactive T cells induce and perpetuate chronic relapsing arthritis |
| Q36027446 | Serum RANKL levels associate with anti- citrullinated protein antibodies in early untreated rheumatoid arthritis and are modulated following methotrexate |
| Q56890888 | Sex-based differences in association between circulating T cell subsets and disease activity in untreated early rheumatoid arthritis patients |
| Q83208728 | Shared susceptibility variations in autoimmune diseases: a brief perspective on common issues |
| Q33519222 | Simultaneous analysis of all single-nucleotide polymorphisms in genome-wide association study of rheumatoid arthritis |
| Q33872866 | Single nucleotide polymorphisms at the TRAF1/C5 locus are associated with rheumatoid arthritis in a Han Chinese population |
| Q33519363 | Single versus multiple imputation for genotypic data. |
| Q37401378 | Specific association of type 1 diabetes mellitus with anti-cyclic citrullinated peptide-positive rheumatoid arthritis |
| Q35011877 | Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis |
| Q33339386 | Specificity of the STAT4 genetic association for severe disease manifestations of systemic lupus erythematosus |
| Q64240473 | Studying the effects of haplotype partitioning methods on the RA-associated genomic results from the North American Rheumatoid Arthritis Consortium (NARAC) dataset |
| Q36376793 | Susceptibility to JRA/JIA: complementing general autoimmune and arthritis traits |
| Q92684874 | Susceptible loci associated with autoimmune disease as potential biomarkers for checkpoint inhibitor-induced immune-related adverse events |
| Q35920930 | Synovial expression of Th17-related and cancer-associated genes is regulated by the arthritis severity locus Cia10. |
| Q24288912 | Systematic analysis, comparison, and integration of disease based human genetic association data and mouse genetic phenotypic information |
| Q37324840 | T cells in rheumatoid arthritis |
| Q37993692 | T-cell receptor signaling and the pathogenesis of autoimmune arthritis: insights from mouse and man. |
| Q39818926 | TCR-CD3ζ gene polymorphisms and expression profile in rheumatoid arthritis. |
| Q24657292 | TRAF1-C5 as a risk locus for rheumatoid arthritis--a genomewide study |
| Q41830089 | TRAF1/C5 but not PTPRC variants are potential predictors of rheumatoid arthritis response to anti-tumor necrosis factor therapy. |
| Q43812054 | The -319C/+49G/CT60G haplotype of CTLA-4 gene confers susceptibility to rheumatoid arthritis in Mexican population |
| Q36801049 | The Development of Novel Therapies for Rheumatoid Arthritis |
| Q37453924 | The ITGAV rs3738919 variant and susceptibility to rheumatoid arthritis in four Caucasian sample sets |
| Q35605624 | The MHC2TA -168A>G gene polymorphism is not associated with rheumatoid arthritis in Austrian patients |
| Q84444178 | The PADI4 gene does not contribute to genetic susceptibility to rheumatoid arthritis in Chinese Han population |
| Q36392280 | The PTPN22 1858C/T polymorphism is associated with anti-cyclic citrullinated peptide antibody-positive early rheumatoid arthritis in northern Sweden |
| Q34661548 | The PTPN22*C1858T functional polymorphism is associated with susceptibility to inflammatory polyarthritis but neither this nor other variants spanning the gene is associated with disease outcome |
| Q35108626 | The expanded human disease network combining protein-protein interaction information. |
| Q37738107 | The genetics of juvenile idiopathic arthritis: what is new in 2010? |
| Q36590524 | The genetics of systemic lupus erythematosus: understanding how SNPs confer disease susceptibility |
| Q36056490 | The protein tyrosine phosphatase N22 gene is associated with juvenile and adult idiopathic inflammatory myopathy independent of the HLA 8.1 haplotype in British Caucasian patients |
| Q58714558 | The protein tyrosine phosphatase PTPN22 negatively regulates presentation of immune complex derived antigens |
| Q50181592 | The relationship of PADI4_94 polymorphisms with the morbidity of rheumatoid arthritis in Caucasian and Asian populations: a meta-analysis and system review |
| Q37817050 | The swollen joint, the thickened artery, and the smoking gun: tobacco exposure, citrullination and rheumatoid arthritis |
| Q42596336 | Thyroxin substitution and the risk of developing rheumatoid arthritis; results from the Swedish population-based EIRA study |
| Q33409947 | Tissue-specific genetic control of splicing: implications for the study of complex traits |
| Q96689535 | Truncated tests for combining evidence of summary statistics |
| Q36788412 | Tumor necrosis factor receptor-associated factor 1 influences KRN/I-Ag7 mouse arthritis autoantibody production |
| Q33706812 | Unchecked CD70 expression on T cells lowers threshold for T cell activation in rheumatoid arthritis |
| Q37729042 | Update on the genetic risk factors for rheumatoid arthritis |
| Q33519311 | Using a higher criticism statistic to detect modest effects in a genome-wide study of rheumatoid arthritis. |
| Q38122628 | Validating therapeutic targets through human genetics |
| Q44532167 | Variants in PTPN22 and SMOC2 genes and the risk of thyroid disease in the Jordanian Arab population |
| Q37755264 | What does the immunogenetic basis of rheumatoid arthritis teach us about the immunobiology of the disease? |
| Q37270709 | What epidemiology has told us about risk factors and aetiopathogenesis in rheumatic diseases |
| Q34026657 | Why is PTPN22 a good candidate susceptibility gene for autoimmune disease? |
| Q83497234 | [Genetics of rheumatoid arthritis] |
| Q85069904 | [How do T-cells become activated in joints?] |